RADIATION THERAPY ONCOLOGY GROUP
RTOG 0924
ANDROGEN DEPRIVATION THERAPY AND HIGH DOSE RADIOTHERAPY WITH OR WITHOUT WHOLE-PELVIC RADIOTHERAPY IN UNFAVORABLE INTERMEDIATE OR FAVORABLE HIGH RISK PROSTATE CANCER: A PHASE III RANDOMIZED TRIAL
RTOG 0924
ANDROGEN DEPRIVATION THERAPY AND HIGH DOSE RADIOTHERAPY WITH OR WITHOUT WHOLE-PELVIC RADIOTHERAPY IN UNFAVORABLE INTERMEDIATE OR FAVORABLE HIGH RISK PROSTATE CANCER: A PHASE III RANDOMIZED TRIAL
Protocol Participation Information
- Credentialing - IMRT
- Credentialing Requirements
- Facility Questionnaire: Part I is required for IMRT on this protocol.
-
RPC Phantom Dosimetry Test
- Fill out the RPC Phantom Request Form to request shipment of a phantom.
- Contact Bill Straube at (314) 362-9762 regarding submission of phantom treatment planning data to the ITC.
- Credentialing - Brachytherapy
Institutions wishing to enter patients onto RTOG protocols that include brachytherapy implants must be credentialed by the Radiological Physics Center (RPC) and demonstrate the ability to submit brachytherapy data electronically to the Image-Guided Therapy QA Center (ITC). Credentialing is for specific personnel, nuclide, manufacturer and model of seed, and treatment planning computer. If anything has changed since your initial credentialing or you wish to use additional seed models, please refer to the RPC website for additional information.
- Data Submission
- RTOG Prostate Brachytherapy Protocol Compliance Form (RPC)
- Digital Data Submission Procedures
- Digital Data Submission Information (DDSI) Form
- ATC Compliant Treatment Planning Systems
- Structure Names
- Study Details Page (http://www.rtog.org)
Back to protocols
